SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed Oct 3, 2017
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2017-09-29+350,000→ 350,000 totalExercise: $3.19Exp: 2027-09-29→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in six equal semi-annual installments over a three-year period beginning September 29, 2017 subject to continued employment by CTIC through the applicable vesting dates.